Countries China
Innovent and HUTCHMED Secure Conditional Approval in China for TYVYT® and ELUNATE® Combo in Advanced Endometrial Cancer
Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
December 04, 2024 | News
Duality Biologics and GSK Forge $1 Billion Partnership for Next-Generation ADC Candidate
Duality Biologics ("DualityBio"), a clinical-stage biotech company focusing on the discovery and development of next-generation antibody-drug conjugate (AD...
December 04, 2024 | News
Everest Medicines Reports Promising Phase 1b/2a Results for EVER001 in Primary Membranous Nephropathy
Patients in the low-dose cohort who have completed 36 weeks of treatment, 9 out of 11 (81.8%) achieved overall clinical remission and 10 out of 11 (91%) ...
December 04, 2024 | News
CBC Group and Mubadala Acquire UCB’s Neurology and Allergy Business in China for $680M
CBC Group and Mubadala acquire UCB’s mature neurology and allergy business in China for US$680 million. New company is named NeuroGen ...
December 02, 2024 | News
Shanghai MicuRx Completes Phase III Trial of MRX-4, Advances Toward NDA Submission in China
Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx", 688373.SH) announced the successful completion of its Phase III clinical trial of MRX-4 for inject...
December 02, 2024 | News
Minghui Pharmaceutical Announces Positive Phase III Results for MH004 Ointment in Treating Atopic Dermatitis
Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, today announced...
December 02, 2024 | News
China’s 2024 National Reimbursement Drug List Expands Access to Cutting-Edge Therapies
The National Healthcare Security Administration of China has unveiled the 2024 National Reimbursement Drug List (NRDL), incorporating several pioneering th...
November 29, 2024 | News
Telix and Grand Pharma Dose First Patient in Phase III ZIRCON-CP Trial for ccRCC Imaging in China
Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) and Grand Pharmaceutical Group Limited (00512.HK, Grand Pharma) announce th...
November 29, 2024 | News
Allink Biotherapeutics Secures $42 Million Series A Funding to Drive Global Expansion of Next-Gen ADC and Bispecific Antibody Therapies
Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutic...
November 29, 2024 | News
Kelun-Biotech Secures China’s First Approval for TROP2-Directed ADC Sacituzumab Tirumotecan for Advanced Triple-Negative Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in China from ...
November 28, 2024 | News
Merck and Abbisko Report Phase III Success for Pimicotinib in TGCT Treatment
Phase III MANEUVER study met primary endpoint, with an objective response rate at week 25 of 54.0% for pimicotinib versus 3.2% for placebo (p<0.0001) ...
November 27, 2024 | News
VectorBuilder and Sartorius Announce Strategic Partnership to Advance Gene Delivery and mRNA Bioprocess Solutions
VectorBuilder, a global leader in end-to-end gene delivery services, and Sartorius, a leading international partner in life science research and the biopha...
November 27, 2024 | News
Duality Biologics and Adcendo Expand Collaboration to Strengthen ADC Cancer Therapy Pipeline
Duality Biologics ("Duality"), a clinical-stage biotech company focusing on the discovery and development of next generation antibody-drug conjugate therap...
November 26, 2024 | News
ArkBio Completes Phase 1 Enrollment for AK0610, Pioneering RSV Prevention for Vulnerable Infants
Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") announced the successful enrollment and dosing of all participants in a Phase 1 clinical study of AK061...
November 25, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
